Clinical trials on antiviral protease inhibitors
| Compounds used in combined therapy | Chemical structure | Disease | Status | Ref. |
|---|---|---|---|---|
| ASC09F + oseltamivir, Ritonavir + oseltamivir, oseltamivir |  | COVID-19 | Phase-3Started in February 1, 2020Ended in July 1, 2020 | [22] |
| Darunavir + cobicistat, lopinavir + ritonavir |  | COVID-19 | Started in March 1, 2020Ended in September 30, 2020 | [23] |
+: combined therapy; Ref.: references